Index · Artikel · AIDS vaccine effects may wear off, researchers say

AIDS vaccine effects may wear off, researchers say

2010-02-19 4
   
Advertisement
résuméWASHINGTON An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported on Thursday. That may explain why results of the expe
Advertisement

AIDS vaccine effects may wear off, researchers say


WASHINGTON An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported on Thursday.

That may explain why results of the experimental vaccine have been so difficult to interpret, said Dr. Nelson Michael, a colonel at the Walter Reed Army Research Institute of Research in Maryland, who helped lead the trial,

Michael's team is trying to find out how or why it might have worked. They surprised the world last September when they showed the experimental vaccine cut the risk of infection by 31 percent over three years.

"It is very likely that this vaccine only worked for a short period of time," Michael said in a telephone interview.

"It is a weak, a modest effect but something that we can build on."

The vaccine is a combination of Sanofi-Pasteur's ALVAC canarypox/HIV vaccine and the HIV vaccine AIDSVAX, made by a San Francisco company called VaxGen and now owned by the nonprofit Global Solutions for Infectious Diseases.

Michael told the Conference on Retroviruses and Opportunistic Infections in San Francisco that it may be possible to design a trial that will show better whether the vaccine can really help people.

Part of the problem, he said, was that the 16,000 Thai volunteers who tested the vaccine were not at especially high risk of AIDS infection.

He said he would work with Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, to design trials in Asia or Africa.

According to the United Nations, more than 33 million people are infected with the fatal and incurable virus, with 2.7 million new infections every year.

Even a vaccine that protected for just a year would be useful, Michael said.

"Is that ideal?" No," Michael said. "But it is true there are vaccines like the flu vaccine where you have to get them every year."

Within the next few weeks, Michael said studies will also start to try to find clues from the blood of the vaccinated volunteers.

"Everyone wants to know why this worked and what lab measurements we could take that could predict this," he said.

Results will take roughly a year, he said, but labs all over the world will be looking for so-called correlates -- measurements such as antibody levels that will show whether a vaccine has affected the immune system in the desired way.

"It is what I call an all-hands-on-deck exercise," he said.

The AIDS virus has killed 25 million people since it was identified in the 1980s. Cocktails of drugs can control HIV but there is no cure. In 2007, Merck & Co ended a trial of its vaccine after it was found not to work, and in 2003, AIDSVAX used alone was found to offer no protection, either.

(Editing by Eric Walsh)

  • AIDS vaccine effects may wear off, researchers say

    AIDS vaccine effects may wear off, researchers say
    WASHINGTON An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported on Thursday. That may explain why results of the expe
    2010-02-19 VACCINEAIDS
  • Study finds potential way to make an AIDS vaccine

    Study finds potential way to make an AIDS vaccine
    WASHINGTON The discovery of immune system particles that attack the AIDS virus may finally open a way to make a vaccine that could protect people against the deadly and incurable infection, U.S. researchers said on Thursday. They used new technology
    2009-09-03 VACCINEAIDS
  • AIDS vaccine protects 1/3 of trial volunteers

    AIDS vaccine protects 1/3 of trial volunteers
    WASHINGTON An experimental AIDS vaccine made using two older vaccines protected volunteers, lowering the risk of infection by about a third, U.S. and Thai researchers reported on Thursday. The vaccine is a combination of Sanofi-Pasteur's ALVAC canary
    2009-09-24 VACCINEAIDS
  • Review confirms AIDS vaccine may have worked

    Review confirms AIDS vaccine may have worked
    PARIS Doctors who surprised the world of AIDS research with a study showing a vaccine prevented some HIV infections released details of their findings on Tuesday and said careful review showed they held up. Full details of the study, which showed the
    2009-10-20 VACCINEAIDS
  • Scientists glean lessons from stalled AIDS vaccine

    Scientists glean lessons from stalled AIDS vaccine
    PARIS Merck and Co's failed AIDS vaccine may not have worked, but it probably did not raise the risk of infection either, doctors said Tuesday. Data analyzed after the large clinical trial was stopped in 2007 contradict earlier findings that suggeste
    2009-10-20 AIDSMERCK
  • Brief shocks may deliver AIDS vaccines better

    Brief shocks may deliver AIDS vaccines better
    PARIS Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said on Thursday. They used a device that looks like a handgun to inject vaccine along with three brief electrical pulses to
  • Scientists see AIDS vaccine within reach after decades

    Scientists see AIDS vaccine within reach after decades
    CHICAGO At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years. But a string of failed attempts - punctuated by a 2007 tr
    2012-07-15 AIDSVACCINES
  • Thailand wins praise for AIDS vaccine trial

    Thailand wins praise for AIDS vaccine trial
    HONG KONG/BANGKOK An experimental AIDS vaccine that appears to be the first to protect people was mired for years in controversy, and credit for its success must go to Thailand where the trial was conducted, experts said. The trial was criticised fiv
    2009-09-28 VACCINEAIDSTHAILAND
  • Antibody finding may help in quest for AIDS vaccine

    Antibody finding may help in quest for AIDS vaccine
    WASHINGTON Researchers have discovered antibodies that can protect against a wide range of AIDS viruses and said they may be able to use them to design a vaccine against the fatal and incurable virus. The bodies of some people make these immune syste
    2010-07-08 AIDSANTIBODIES
  • Many forks loom in road to AIDS vaccine

    Many forks loom in road to AIDS vaccine
    WASHINGTON AIDS experts and advocates gathering in Vienna this weekend for a conference on the pandemic will hear about progress in protecting people from the deadly virus using drugs, and ways to affect behavior. No breakthrough news is expected on
    2010-07-17 AIDSVACCINES
  • Merck shingles vaccine effective in adults in 50s

    Merck shingles vaccine effective in adults in 50s
    NEW YORK In a huge study aimed at broadening the use of Merck & Co's shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo in adults in their 50s, the company said. The 22,439-subject study moni
    2010-10-21 MERCKSHINGLES
  • Syrian government says aid, vaccinations will reach all

    Syrian government says aid, vaccinations will reach all
    BEIRUT The Syrian government promised on Monday to ensure delivery of vaccinations and humanitarian aid across the country, after an outbreak of polio in the northeast and warnings of malnutrition in areas under military siege. Twenty-two children in
    2013-11-04 AIDSYRIACRISIS
  • Studie des Tages: Wissenschaftler Disarm HIV, gehen Sie näher an AIDS Vaccine

    Studie des Tages: Wissenschaftler Disarm HIV, gehen Sie näher an AIDS Vaccine
    Neue Forschungsergebnisse Charts ein Weg der Infektion und die Verbesserung der Immunantwort auf das Virus zu verhindern , dass rund 1,8 Millionen pro Jahr tötet PROBLEM: HIV / AIDS sterben rund 1,8 Millionen Menschen pro Jahr, und gilt als die dritt
    2011-09-20
  • AIDS groups call for "renaissance" in vaccine hunt

    AIDS groups call for "renaissance" in vaccine hunt
    VIENNA Scientists searching for the Holy Grail of a vaccine against the incurable AIDS virus say recent encouraging steps should now galvanize efforts to use limited funds in smarter ways to drive the field forward. International AIDS vaccine advocat
    2010-07-18 AIDSVACCINESSEARCH
  • Experts study thriving HIV "controllers" in vaccine search

    Experts study thriving HIV "controllers" in vaccine search
    PARIS AIDS researchers want to expand their study of a rare group of HIV-infected people, whose immune systems naturally and mysteriously prevent the virus thriving in their bodies, to span the globe. Studies of these "elite controllers," which
    2009-10-21 AIDSCONTROLLERS
  • Study in monkeys raises hope for HIV vaccines

    Study in monkeys raises hope for HIV vaccines
    CHICAGO An experimental vaccine helped protect monkeys from an especially deadly form of the AIDS virus, raising new hope for an effective vaccine in people, U.S. researchers said on Wednesday. The vaccine reduced the risk of infection by 80 percent
    2012-01-04 VACCINEHIV
  • U.S. health officials back safety of Merck vaccine

    U.S. health officials back safety of Merck vaccine
    WASHINGTON U.S. health officials again backed on Thursday the safety of Merck & Co Inc's vaccine to prevent infection by a virus that causes most cases of cervical cancer. The Gardasil vaccine "continues to be safe and effective, and its benefits
    2009-08-20 MERCKGARDASIL
  • Parents delaying, skipping recommended vaccines

    Parents delaying, skipping recommended vaccines
    NEW YORK (Reuters Health) - More than one in 10 parents use an "alternative" vaccination schedule for their young children, including refusing vaccines altogether, according to a U.S. survey. Based on the findings, researchers worry that more pa
    2011-10-03 VACCINES
  • U.N. says millions still lack access to AIDS drugs

    U.N. says millions still lack access to AIDS drugs
    LONDON More than half of the 9.5 million people who need AIDS drugs cannot get them and 33 million people across the world are still infected with the virus that causes it, a United Nations report said on Wednesday. Access to drugs, counseling and te
    2009-09-30 AIDSPROGRESS
  • New survey suggests Americans keen for H1N1 vaccine

    New survey suggests Americans keen for H1N1 vaccine
    WASHINGTON Days before the swine flu vaccine becomes available, more than half of U.S. adults say they will get the vaccine for themselves and 75 percent will get it for their children, according to a survey released on Friday. Forty percent said the
    2009-10-02 FLUVACCINESURVEY

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated